Research into 5-Amino-1MQ has been conducted primarily in preclinical (animal and cellular) models, and it has not been approved by the MHRA, NICE, or any major regulatory authority for human therapeutic use
Avoid repeated freezethaw cycles
Although the number of injections that would be administered would very much depend on the extent of the nerve damage, they are normally administered over several weeks or months
For hematocrit and reticulocyte counts, recommendations are to repeat these tests daily from the 5th to 7th days of treatment and then frequently until the hematocrit returns to a normal range (11, 14, 15)
Although it isnt FDA-approved for general weight loss, some people use it off-label
This ensures the treatment is working as well as it can